<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T20:30:43+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>独家专访！加快医药“产学研”一体化模式建设，其关键3点因素</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/yR8-pGxyekE348IndJ7Asw</id>
    <link href="https://mp.weixin.qq.com/s/yR8-pGxyekE348IndJ7Asw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020| BCMA靶点开发：CAR-T、双抗、抗体偶联药物谁将率先胜出？</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/vzU90IsRfj0MrL_QNzA2tQ</id>
    <link href="https://mp.weixin.qq.com/s/vzU90IsRfj0MrL_QNzA2tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采3进2，代理商的好机会？</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/MGAtlxh7kHTokWcFEzrW3g</id>
    <link href="https://mp.weixin.qq.com/s/MGAtlxh7kHTokWcFEzrW3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药监局出台GVP明确了药物警戒主体责任的承担者，将冲击所有MAH</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/Z7KZxSBGYvhrly3KXh5UEw</id>
    <link href="https://mp.weixin.qq.com/s/Z7KZxSBGYvhrly3KXh5UEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【更新版】药品技术转移、工艺验证和清洁验证最新要求与合规操作</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/f2nu9kAjXm9bwu1nQjPtDQ</id>
    <link href="https://mp.weixin.qq.com/s/f2nu9kAjXm9bwu1nQjPtDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“贱卖”核心资产遭质疑：风口浪尖的「沃森生物」如何平息风波？</title>
    <updated>2020-12-07T16:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/PWSqsQ_Q10q25EX-sjty2A</id>
    <link href="https://mp.weixin.qq.com/s/PWSqsQ_Q10q25EX-sjty2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“带金销售”终结！代表备案，大批医药人恐被淘汰</title>
    <updated>2020-12-07T16:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/6KbB-tXLYICBNzj9cL8FCg</id>
    <link href="https://mp.weixin.qq.com/s/6KbB-tXLYICBNzj9cL8FCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国生物制药注资5亿，科兴中维疫苗产能或将“翻倍”</title>
    <updated>2020-12-07T16:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/kMcxXWjASeERnI42pS7sHQ</id>
    <link href="https://mp.weixin.qq.com/s/kMcxXWjASeERnI42pS7sHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>流感需重视，别让“小感冒”酿成了大病</title>
    <updated>2020-12-07T16:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/NuEtz29nosijTV0gjNaLmA</id>
    <link href="https://mp.weixin.qq.com/s/NuEtz29nosijTV0gjNaLmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药咖君】首个国产 PARP 抑制剂即将获批！麻醉剂市场迎来1.1类新药，恒瑞、正大天晴、海思科…</title>
    <updated>2020-12-05T11:03:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/1tdvLdBvsqieQLB7SACEAg</id>
    <link href="https://mp.weixin.qq.com/s/1tdvLdBvsqieQLB7SACEAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【一周君】医保局透露：集采终于要对“中成药”动刀了；“互联网+”医疗服务纳入医保支付提上日程；健之佳上市：零售药店上市药企...</title>
    <updated>2020-12-05T11:01:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/1M30U8skNjqlVZuBFXkKVQ</id>
    <link href="https://mp.weixin.qq.com/s/1M30U8skNjqlVZuBFXkKVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第三批国家集采药品全国落地！重压下，企业只能降价调价以求中标？</title>
    <updated>2020-12-05T11:01:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/Pj5jUEVsM9q9WWXkGJ2w9Q</id>
    <link href="https://mp.weixin.qq.com/s/Pj5jUEVsM9q9WWXkGJ2w9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药不能停！地方集采速度要加快了</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/-sTL48RQXMXLrVZVX3umbw</id>
    <link href="https://mp.weixin.qq.com/s/-sTL48RQXMXLrVZVX3umbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】 7款超10亿重磅注射剂过评，豪森「培美曲塞二钠」、扬子江「紫杉醇」、奥赛康「兰索拉唑」......</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Q7ceQx7f36Nj0jOHBx8Lxw</id>
    <link href="https://mp.weixin.qq.com/s/Q7ceQx7f36Nj0jOHBx8Lxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辅仁药业所持股份100%被冻结，借款余额减少下，日子仍旧难过</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yIM1p7r9ugVyolOulZu6CA</id>
    <link href="https://mp.weixin.qq.com/s/yIM1p7r9ugVyolOulZu6CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企注意！33个大品种带量采购，申报开始</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/IPfPocpuBmFdnCB5CdCpwQ</id>
    <link href="https://mp.weixin.qq.com/s/IPfPocpuBmFdnCB5CdCpwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE药审分析， BET、GCS、BTK 等靶点新药申报受理，贝达、复星、赛诺菲…</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/1SZi4pS1_MW8hcwEhrHfHg</id>
    <link href="https://mp.weixin.qq.com/s/1SZi4pS1_MW8hcwEhrHfHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>突破历史！恒瑞新药报产与临床获批双高，4款1类新药上市在即</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/4rulrVW8OQQApWD0Ew71tQ</id>
    <link href="https://mp.weixin.qq.com/s/4rulrVW8OQQApWD0Ew71tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏：开展三款新冠疫苗采购，国药、科兴...</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/9xf4aeO4d_ChQ-quLxh1pg</id>
    <link href="https://mp.weixin.qq.com/s/9xf4aeO4d_ChQ-quLxh1pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫苗行业突发重大利好，跨年行情或将迎来国产“新冠疫苗”？</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/qGuouqp3xmznTRBhWldC7g</id>
    <link href="https://mp.weixin.qq.com/s/qGuouqp3xmznTRBhWldC7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>